French Competition Authority Clears GL events Acquisition of Fimalac Entertainment Venue Activities

The French Competition Authority (ADLC) has cleared the acquisition of Fimalac's entertainment venue and exhibition centre management activities by GL events, subject to commitments. These commitments are behavioural remedies focused on the Marne department to address identified competition risks.

WHO HRP Receives $7.2M Funding Commitment for Sexual and Reproductive Rights

The Children's Investment Fund Foundation (CIFF) has committed US$ 7.2 million to the WHO's HRP programme for research in human reproduction. This funding aims to advance sexual and reproductive health and rights globally, particularly in light of cuts to development assistance.

WHO Guidance on Institutionalizing Health Emergency Simulation Exercises

The WHO has released new global guidance to help countries establish National Health Simulation Exercise Programmes (NHSEP). This guidance encourages a shift from ad-hoc drills to structured, government-led programs for testing and strengthening health emergency preparedness.

B. Braun Medical Inc. Urgent Correction for Hemodialysis Bloodlines

B. Braun Medical Inc. issued an urgent medical device correction for specific hemodialysis bloodlines due to the potential formation of air bubbles. The FDA is issuing an Early Alert to notify the public and advise healthcare providers to use alternate equipment or follow specific mitigation steps if the affected devices must be used.

Rivaroxaban Viatris Lot Recalled Due to Quetiapine Contamination

The French ANSM has ordered a recall of a specific lot (8212020) of Rivaroxaban Viatris 20mg tablets due to cross-contamination with quetiapine. Patients holding this lot are advised to return it to pharmacies for exchange.

ANSM Suspends Institut Georges Lopez, Recalls Celsior Lots

The French ANSM has suspended the manufacturing authorization for Institut Georges Lopez (IGL) and recalled all lots of its organ preservation solution, Celsior, produced since March 2024 due to serious manufacturing non-conformities posing a high risk of microbiological contamination. An update on March 25, 2026, indicates IGL has come into compliance, and its manufacturing authorization has been reinstated.

Guangdong-Hong Kong-Macao-Shenzhen Joint Financial Regulatory Meeting Held

The Hong Kong Monetary Authority announced the inaugural Guangdong-Hong Kong-Macao-Shenzhen Joint Financial Regulatory Meeting. The meeting focused on industry developments, supervisory work, and market trends, including AI in banking and cross-boundary insurance services.

HKMA 2026 Pay Review Results

The Hong Kong Monetary Authority (HKMA) announced the results of its 2026 annual pay review, approving a 2.65% general increase in fixed pay for staff. An additional allocation of 1.35% of fixed pay is set aside for performance awards, and variable pay equivalent to 20.04% of total pay will be distributed based on 2025 performance.

HKMA Alerts Public to Bank Scams and Fraudulent Websites

The Hong Kong Monetary Authority (HKMA) has issued a scam alert regarding fraudulent websites and other scams targeting customers of several banks. The alert provides a list of affected banks and advises the public on how to protect themselves and report suspicious activity.

RMB Bills Tender Result

The Hong Kong Monetary Authority (HKMA) announced the results of the People's Bank of China RMB Bills tender held on March 25, 2026. RMB 60 billion in six-month RMB Bills were issued at an average coupon rate of 1.40%.